DK72691A - Behandling af hypertension - Google Patents

Behandling af hypertension Download PDF

Info

Publication number
DK72691A
DK72691A DK072691A DK72691A DK72691A DK 72691 A DK72691 A DK 72691A DK 072691 A DK072691 A DK 072691A DK 72691 A DK72691 A DK 72691A DK 72691 A DK72691 A DK 72691A
Authority
DK
Denmark
Prior art keywords
potassium
preferred
hypertension
treatment
methods
Prior art date
Application number
DK072691A
Other languages
English (en)
Other versions
DK72691D0 (da
DK175841B1 (da
Inventor
Jr Curtis R Morris
Anthony Sebastian
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of DK72691D0 publication Critical patent/DK72691D0/da
Publication of DK72691A publication Critical patent/DK72691A/da
Application granted granted Critical
Publication of DK175841B1 publication Critical patent/DK175841B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/42—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Display Devices Of Pinball Game Machines (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK199100726A 1988-10-21 1991-04-19 Behandling af hypertension DK175841B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US26085688A 1988-10-21 1988-10-21
US26085688 1988-10-21
PCT/US1989/004771 WO1990004403A1 (en) 1988-10-21 1989-10-20 Treatment of hypertension
US8904771 1989-10-20

Publications (3)

Publication Number Publication Date
DK72691D0 DK72691D0 (da) 1991-04-19
DK72691A true DK72691A (da) 1991-04-22
DK175841B1 DK175841B1 (da) 2005-03-29

Family

ID=22990921

Family Applications (2)

Application Number Title Priority Date Filing Date
DK199100727A DK175840B1 (da) 1988-10-21 1991-04-19 Behandling af osteoporose
DK199100726A DK175841B1 (da) 1988-10-21 1991-04-19 Behandling af hypertension

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK199100727A DK175840B1 (da) 1988-10-21 1991-04-19 Behandling af osteoporose

Country Status (13)

Country Link
US (1) US5804204A (da)
EP (3) EP0720855A3 (da)
JP (2) JP2948247B2 (da)
KR (2) KR0178033B1 (da)
AT (1) ATE145825T1 (da)
AU (2) AU635231B2 (da)
CA (2) CA2001123C (da)
DE (2) DE68927519T2 (da)
DK (2) DK175840B1 (da)
HU (2) HU208923B (da)
IL (2) IL92075A (da)
WO (2) WO1990004402A1 (da)
ZA (2) ZA898017B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5674529A (en) * 1995-06-06 1997-10-07 Church & Dwight Co., Inc. Alkalinizing potassium salt controlled release preparations
AT408416B (de) * 1996-07-19 2001-11-26 Norbert Fuchs Pharmazeutische bzw. diätetische zusammensetzungen
WO2003086423A1 (en) * 2002-04-05 2003-10-23 Btg International Limited Low-dose potassium supplementation for the prevention and treatment of hypertension
EP1350515A1 (en) * 2002-04-05 2003-10-08 Btg International Limited Low-dose potassium supplementation for the prevention and treatment of hypertension
US20040202726A1 (en) * 2003-04-10 2004-10-14 Deshay Samuel L. Topical blood pressure composition
US10251909B2 (en) * 2007-02-09 2019-04-09 Board Of Regents, The University Of Texas System Potassium-magnesium citrate as a surrogate of the DASH diet in managing hypertension
US20090022853A1 (en) * 2007-07-16 2009-01-22 Conopco, Inc., D/B/A Unilever Beverage
MX2010008625A (es) * 2008-02-06 2010-09-14 Campbell Soup Co Metodos y composiciones para reducir el contenido de sodio en productos alimenticios.
ATE537710T1 (de) * 2008-09-05 2012-01-15 Unilever Nv Getränke, die kalium enthalten
WO2022073459A1 (zh) * 2020-10-09 2022-04-14 刘志 吸入制剂及其制备方法和应用
CN114272263A (zh) * 2022-01-10 2022-04-05 伍永田 一种用于治疗高血压疾病的水配方
CN116819083B (zh) * 2023-06-20 2025-05-27 齐鲁工业大学(山东省科学院) 一种基于重组人肾素分子印迹聚合物的电化学生物传感器、制备方法及应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2611730A (en) * 1950-09-02 1952-09-23 Simth Kline & French Lab Medical preparation for reducing the body level of sodium
GB1195381A (en) * 1967-04-28 1970-06-17 Arthur H Cox & Company Ltd Pharmaceutical Compositions Comprising Potassium and Chlorine
US3639585A (en) * 1968-03-29 1972-02-01 Res Inst Medicine Chem Method of preventing corticosteroid-induced adverse effects on bon and compositions useful in said method
US3541208A (en) * 1968-09-10 1970-11-17 Arcom Holding Corp Relief of arthritis with a soluble silicate and a soluble polyphosphate
US3921804A (en) * 1974-05-09 1975-11-25 William W Tester Medication dispensing package
SU858830A1 (ru) * 1974-10-23 1981-08-30 Институт медико-биологических проблем Средство дл лечени нарушений ритма сердца
SU946545A1 (ru) * 1978-05-04 1982-07-30 Институт Медико-Биологических Проблем Министерства Здравоохранения Ссср Способ восполнени калиевого дефицита в ткан х
FR2432869A1 (fr) * 1978-08-08 1980-03-07 Armour Montagu Laboratoire Compositions pour le traitement de l'osteoporose associant la calcitonine et le phosphore
US4405596A (en) * 1978-10-16 1983-09-20 Helbig Joachim W Pharmaceutical preparations for and treatment procedures involving increasing plasma bicarbonate level
US4289750A (en) * 1978-10-16 1981-09-15 Kopp Klaus F Therapy of conditions which may be associated with altered renal function and dosage forms therefor
US4451454A (en) * 1981-06-16 1984-05-29 Wong Dennis W Prophylaxis and treatment of thromboembolic disorders in man and in warm-blooded animals with bicarbonate salts of alkali metals
US4704269A (en) * 1985-06-11 1987-11-03 Hudson Pharmaceutical Corporation Effervescent antacid and analgesic compositions
JPH0619063B2 (ja) * 1986-04-09 1994-03-16 日本エステル株式会社 粉体塗料用樹脂組成物

Also Published As

Publication number Publication date
HUT63058A (en) 1993-07-28
US5804204A (en) 1998-09-08
JPH04501419A (ja) 1992-03-12
ZA898018B (en) 1990-12-28
DE68913311D1 (de) 1994-03-31
WO1990004403A1 (en) 1990-05-03
HU896567D0 (en) 1991-07-29
HU896889D0 (en) 1991-07-29
WO1990004402A1 (en) 1990-05-03
CA2001124C (en) 2000-01-18
HU208923B (en) 1994-02-28
DE68927519T2 (de) 1997-04-03
EP0440738A4 (en) 1991-08-28
KR0178033B1 (ko) 1999-03-20
EP0461111A4 (en) 1991-07-25
CA2001124A1 (en) 1990-04-21
HU212106B (en) 1996-02-28
IL92075A0 (en) 1990-07-12
EP0720855A2 (en) 1996-07-10
IL92076A (en) 1995-08-31
DK72691D0 (da) 1991-04-19
JP2948247B2 (ja) 1999-09-13
KR900701288A (ko) 1990-12-01
DE68927519D1 (de) 1997-01-16
EP0440738A1 (en) 1991-08-14
KR900701287A (ko) 1990-12-01
AU4515489A (en) 1990-05-14
DE68913311T2 (de) 1994-05-26
EP0720855A3 (en) 1998-07-08
CA2001123C (en) 2000-01-18
JP2843146B2 (ja) 1999-01-06
JPH04501724A (ja) 1992-03-26
IL92075A (en) 1995-07-31
EP0461111B1 (en) 1994-02-23
DK72791A (da) 1991-05-14
DK72791D0 (da) 1991-04-19
ZA898017B (en) 1990-12-28
AU4622089A (en) 1990-05-14
IL92076A0 (en) 1990-07-12
CA2001123A1 (en) 1990-04-21
DK175840B1 (da) 2005-03-29
EP0461111A1 (en) 1991-12-18
KR0163583B1 (ko) 1998-12-01
EP0440738B1 (en) 1996-12-04
HUT57989A (en) 1992-01-28
DK175841B1 (da) 2005-03-29
AU635231B2 (en) 1993-03-18
ATE145825T1 (de) 1996-12-15
AU634988B2 (en) 1993-03-11

Similar Documents

Publication Publication Date Title
DK72691D0 (da) Behandling af hypertension
IT8419266A1 (it) Dispositivo per generare calore in tessuti" del corpo umano e procedimento di cenerazione di calore, particolarmente per la cura di tumori
DE69532961D1 (de) Verwendung von porphyrine in der behandlung von multiple sklerose
NO307546B1 (no) Farmasøytisk preparat inneholdende optisk ren R-ketorolak samt anvendelse derav
PT97785A (pt) Metodo para a tratamento da impotencia utilizando, por exemplo, doxazosina
NO20000087L (no) Behandling av inflammatoriske sykdommer i tarmen og urinblære
DK0512883T3 (da) Fremgangsmåde til fremstilling af et koncentrat af blodkoaguleringsfaktor XI med høj specifik aktivitet, til terapeutisk anvendelse
FI953565A7 (fi) Uusi antikoagulanttikofaktoriaktiivisuus
NO894222L (no) Fremgangsmaater for behandling og profylakse av pneumocytis carinii pneumoni og andre sykdommer og forbindelser og formuleringer for anvendelse i nevnte metoder.
EP0350738A3 (de) (S)-Emopamil zur Anwendung bei der Behandlung von Migräne
DK0590355T3 (da) Anvendelse af L-carnitin og acyl-L-carnitiner til behandling af patienter, der lider af AIDS-relaterede syndromer og asymptomatiske HIV-seropositive patienter
ES2087764T3 (es) Uso del ajo de oso en el tratamiento o prevencion de los trastornos circulatorios.
DK0859630T3 (da) Kombination af termozolomid og alfa-IFN til behandling af fremskreden cancer
GR3006147T3 (da)
IT1246050B (it) Impiego dell'eptastigmina nella terapia dell'ictus cerebrale.
RU93006337A (ru) Способ лечения хронического остеомиелита
DE3776662D1 (de) Pharmazeutische zusammensetzungen zur behandlung von hyperproliferativer hautkrankheit.
SE9704451D0 (sv) New method and compositions for the treatment of autoimmune diseases
EA199700034A2 (ru) Способ в.г.соломатова коррекции энергетического состояния живого существа
SE8800838D0 (sv) Komposition for tillsats till sprayvatten vid tandbehandling
RU93025242A (ru) Способ лазеротерапии
UA26407C2 (uk) Спосіб очищеhhя уражеhих шкірhих покривів людиhи при захворюваhhі псоріазом
BG51278A1 (en) Method for potentiation of the therapeutical effect of human recombination erythropoietin
MY117556A (en) Methods and formulations for modulating the human sexual response

Legal Events

Date Code Title Description
PBP Patent lapsed

Country of ref document: DK